SOLENO THERAPEUTICS INC (SLNO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SLNO currently has 46.2M outstanding shares. with significant dilution risk as 59M authorized shares could dilute existing holders by 127.8%. The company has diluted shareholders by 18.61% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2025 |
10-Q filing | 46.2M shares outstanding |
46M | 59M |
| Feb 28, 2025 |
10-K filing | 45.9M shares outstanding |
46M | 59M |
| Nov 06, 2024 |
10-Q filing | 41.9M shares outstanding |
42M | 63M |
| Aug 07, 2024 |
10-Q filing | 38.6M shares outstanding |
39M | 67M |
| May 09, 2024 |
10-Q filing | 36.2M shares outstanding |
36M | 69M |
| Mar 07, 2024 |
10-K filing | 32.5M shares outstanding |
32M | 73M |
| Nov 08, 2023 |
10-Q filing | 30.5M shares outstanding |
30M | 75M |
| Oct 20, 2023 |
S-3 filing: Resale of up to 3,000,000 shares of common stock by selling stockholders. |
10M | 95M |
| Aug 08, 2023 |
10-Q filing | 10.4M shares outstanding |
10M | 92M |
| Jul 28, 2023 |
S-1/A filing: The filing relates to the resale of up to 22,598,870 shares of common stock underlying warrants by selling stockholders. |
8.2M | 94M |
| Jul 21, 2023 |
S-1 filing: S-1 filing for Soleno Therapeutics, Inc. regarding the resale of up to 22,598,870 shares of common stock underlying warrants by selling stockholders. |
8.2M | 94M |
| May 09, 2023 |
10-Q filing | 8.2M shares outstanding |
8.2M | 71M |
| Mar 22, 2023 |
10-K filing | 8.4M shares outstanding |
8.4M | 71M |
| Nov 09, 2022 |
10-Q filing | 8.1M shares outstanding |
8.1M | 71M |
| Aug 10, 2022 |
10-Q filing | 120.1M shares outstanding |
120M | 0 |
| May 10, 2022 |
10-Q filing | 120.1M shares outstanding |
120M | 0 |
| Mar 31, 2022 |
10-K filing | 80.1M shares outstanding |
80M | 0 |
| Nov 10, 2021 |
10-Q filing | 79.8M shares outstanding |
80M | 0 |
| Jul 28, 2021 |
10-Q filing | 79.8M shares outstanding |
80M | 0 |
| May 05, 2021 |
10-Q filing | 79.7M shares outstanding |
80M | 0 |
| Mar 03, 2021 |
10-K filing | 79.7M shares outstanding |
80M | 0 |
| Jan 14, 2021 |
S-3 filing: S-3 filing for Soleno Therapeutics, Inc. indicating a potential offering of up to $100,000,000 in common stock and warrants. |
80M | 0 |
| Nov 10, 2020 |
10-Q filing | 79.6M shares outstanding |
80M | 0 |
| Aug 10, 2020 |
10-Q filing | 79.6M shares outstanding |
80M | 0 |
| May 12, 2020 |
10-Q filing | 44.7M shares outstanding |
45M | 0 |
| Mar 04, 2020 |
10-K filing | 44.7M shares outstanding |
45M | 0 |